Clinical Evaluation of Nano Hydroxyapatite Reinforced Glass Ionomer in Treatment of Root Caries in Geriatric Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04701320 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 8, 2021
Last Update Posted : January 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dental Restoration Failure | Drug: Conventional glass ionomer Drug: Nano hydroxyapatite reinforced glass ionomer | Phase 1 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 20 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Clinical Evaluation of Nano Hydroxyapatite Reinforced Glass Ionomer Versus Conventional Glass Ionomer in Treatment of Root Caries in Geriatric Patients: A Randomized Controlled Clinical Trial |
| Actual Study Start Date : | July 7, 2019 |
| Actual Primary Completion Date : | July 7, 2019 |
| Estimated Study Completion Date : | August 9, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Glass carbomer
Nano hydroxyapatite Reinforced Glass Ionomer that results in chemical bond formation with tooth structure mimic that of enamel tissue
|
Drug: Nano hydroxyapatite reinforced glass ionomer
Nanohydroxyapatite reinforced glass ionomer restorative material with enhanced mechanical proberties and chemical adhesion to tooth structure
Other Name: Glass carbomer |
|
Active Comparator: Fuji ix
Conventional Glass Ionomer cement fluoride-releasing restorative system that combines fluoride release of glass ionomer cement and acceptable esthetics, a wear resistant, self-adhesive
|
Drug: Conventional glass ionomer
Conventional glass ionomer with enhanced mechanical and esthetic proberties
Other Name: Fujiix gc corporation |
- Clinical restorative performance Service (USHPS) [ Time Frame: Change from the baseline at 3, 6 and12 months ]Change in the clinical behavior of the restoration (e.g. anatomical contour, shade match, secondary caries) using modified United State Public Health clinical evaluation assessment method Service (USHPS)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 50 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
-
• ≥ 50 years old
- Males or females.
- Community-dwelling
- Have five or more of their own teeth
- With ≥ 1 root caries lesion
Exclusion Criteria:
-
• Patients younger than 50 years old
- Disabilities.
- Systemic diseases or severe medically compromised.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04701320
| Egypt | |
| Faculty of dentistry | |
| Cairo, Egypt, 002 | |
| Responsible Party: | Reham nabil mahmoud, associate lecturer, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04701320 |
| Other Study ID Numbers: |
OPER 3-3-6 |
| First Posted: | January 8, 2021 Key Record Dates |
| Last Update Posted: | January 8, 2021 |
| Last Verified: | January 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Supporting Materials: |
Study Protocol |
| Time Frame: | one year |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Glass Carbomer GCP glass fill root caries Clinical perfomance |
|
Root Caries Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases Methamphetamine Central Nervous System Stimulants Physiological Effects of Drugs Sympathomimetics Autonomic Agents |
Peripheral Nervous System Agents Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Dopamine Uptake Inhibitors |

